Psychiatry and Neurology, Neurology · Waterloo, IA
NPI
1477765584
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2710 Saint Francis Dr, Suite 104
Waterloo, IA, 50702
Phone (319) 272-6733
Groups this clinician bills Medicare through
Medicare paid, 2024
$189K
4,193 services
Medicare patients, 2024
970
Average age 74
Drug cost, 2024
$1.3M
8,274 prescriptions
Company payments, 2025
$1,020
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sangeeta Shah was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 1,606 times for 828 patients. In total Sangeeta Shah billed 4,193 services in 22 codes, and Medicare paid $189K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-05-31.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 1,606 | 828 | $11.37 | $18K |
| 99214 Office E&M - Established | Facility | 1,202 | 591 | $63.52 | $76K |
| 99204 Office E&M - New | Facility | 370 | 370 | $85.64 | $32K |
| 99215 Office E&M - Established | Facility | 202 | 142 | $101.59 | $21K |
| 95885 Electrical Nerve Conductivity | Facility | 175 | 138 | $13.19 | $2,308 |
| 95886 Electrical Nerve Conductivity | Facility | 132 | 105 | $31.73 | $4,188 |
| 95911 Electrical Nerve Conductivity | Facility | 121 | 117 | $91.31 | $11K |
| 95909 Electrical Nerve Conductivity | Facility | 96 | 93 | $53.71 | $5,156 |
| 95910 Electrical Nerve Conductivity | Facility | 54 | 53 | $67.71 | $3,656 |
| 99203 Office E&M - New | Facility | 51 | 51 | $52.82 | $2,694 |
| 64615 Musculoskeletal | Facility | 43 | 15 | $72.18 | $3,104 |
| 64616 Musculoskeletal | Facility | 28 | 11 | $102.92 | $2,882 |
| 99213 Office E&M - Established | Facility | 18 | 18 | $24.19 | $435 |
| 95912 Electrical Nerve Conductivity | Facility | 17 | 17 | $109.68 | $1,865 |
| 99205 Office E&M - New | Facility | 13 | 13 | $126.96 | $1,650 |
By year: 2022 $171K for 2,505 services; 2023 $152K for 2,362 services; 2024 $189K for 4,193 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sangeeta Shah prescribed most often to Medicare patients was Donepezil Hcl, with 1,400 prescriptions and refills. In total Sangeeta Shah wrote 8,274 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 1,400 | 2,313 | 282 | $11K |
| Memantine Hcl Generic | 1,096 | 1,742 | 201 | $38K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 642 | 1,136 | 128 | $18K |
| Gabapentin Generic | 506 | 844 | 112 | $8,231 |
| Levetiracetam Generic | 405 | 729 | 78 | $11K |
| Topiramate Generic | 280 | 506 | 54 | $5,487 |
| Lamotrigine Generic | 203 | 333 | 36 | $4,123 |
| Lacosamide Generic | 184 | 244 | 21 | $36K |
| Amitriptyline Hcl Generic | 165 | 254 | 31 | $2,602 |
| Primidone Generic | 151 | 275 | 33 | $5,963 |
| Rivastigmine Rivastigmine Tartrate | 140 | 179 | 24 | $7,178 |
| Escitalopram Oxalate Generic | 138 | 224 | 29 | $1,136 |
| Risperidone Generic | 121 | 160 | 27 | $667 |
| Propranolol Hcl Generic | 111 | 207 | 27 | $1,343 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 105 | 186 | 24 | $6,389 |
Brand drugs: 522 claims; generic drugs: 7,696 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sangeeta Shah $1,020 ($1,020 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $230.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 21 | $230 |
| Teva Pharmaceuticals USA, Inc. TEVA | 4 | $144 |
| Lilly USA, LLC LLY | 5 | $82.84 |
| Celgene Corporation BMY | 4 | $75.95 |
| Lundbeck LLC | 4 | $73.09 |
| Pfizer Inc. PFE | 3 | $53.53 |
| SK Life Science, Inc. | 3 | $52.86 |
| Genentech USA, Inc. ROG.SW | 2 | $44.72 |
| EMD Serono, Inc. MRK.DE | 2 | $43.44 |
| Alexion Pharmaceuticals, Inc. AZN | 2 | $42.22 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.